Current understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trials.
about
Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profileAssociation of ABCC2 -24C>T polymorphism with high-dose methotrexate plasma concentrations and toxicities in childhood acute lymphoblastic leukemiaAn ancient riboswitch class in bacteria regulates purine biosynthesis and one-carbon metabolismThe association of reduced folate carrier 80G>A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy numberLeptin consumption in the inflamed joints of patients with rheumatoid arthritisCo-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance.Prodrug forms of N-[(4-deoxy-4-amino-10-methyl)pteroyl]glutamate-gamma-[psiP(O)(OH)]-glutarate, a potent inhibitor of folylpoly-gamma-glutamate synthetase: synthesis and hydrolytic stability.Maternal tea consumption during early pregnancy and the risk of spina bifidaIdentification of genes associated with methotrexate resistance in methotrexate-resistant osteosarcoma cell lines.The Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Methotrexate ProphylaxisMechanisms and insights into drug resistance in cancerIncreased Ghrelin but Low Ghrelin-Reactive Immunoglobulins in a Rat Model of Methotrexate Chemotherapy-Induced Anorexia.Involvement of CD147 on multidrug resistance through the regulation of P-glycoprotein expression in K562/ADR leukemic cell line.Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival.Embryonic stem cells lacking the epigenetic regulator Cfp1 are hypersensitive to DNA-damaging agents and exhibit decreased Ape1/Ref-1 protein expression and endonuclease activity.Methotrexate and 5-aminoimidazole-4-carboxamide riboside exert synergistic anticancer action against human breast cancer and hepatocellular carcinoma.Nanopreparations to overcome multidrug resistance in cancer.Emulsomes meet S-layer proteins: an emerging targeted drug delivery system.The Different Mechanisms of Cancer Drug Resistance: A Brief Review.The effect of intravenous hydration strategy on plasma methotrexate clearance during intravenous high-dose methotrexate administration in pediatric oncology patients
P2860
Q28073956-3CA747D0-15FC-4C95-8A5E-6CA06185D447Q28472573-C08787B0-E72F-4118-9756-C47F39EE9B9BQ28538292-CC5EA5F0-ED3A-4E91-A6E8-12AAC76BC1AAQ28610747-D97132BA-1597-42CD-97B5-10F4BE2C5AA9Q33931844-3837EBAF-CC18-40A3-B3CB-F3EEE087DA1BQ35552048-97E6B491-C8E3-4DDC-A290-69241769852AQ35924301-8D5E8A8D-53F7-4680-9DB7-CB03DC36D397Q35989715-5BB67A49-3D26-4440-A19F-49E966D79AC2Q36019883-F874DF80-3459-42BF-8E53-738D4ACB136AQ36022718-4E0674F5-B5B2-4691-8DB1-A1C0B45860FCQ36175130-8209BCEC-D015-412E-99DD-D68A78B0B0E5Q36682301-9752116F-5EA2-4B81-BE9E-3D90D3D00A75Q37124526-3F61BEA9-EC92-460A-A4A8-3AA2AA264A55Q37253732-867B673F-CEE2-4BDB-A72A-63272888927CQ37369929-C2274495-05E8-41FE-ACF4-97F981425F73Q37455875-0D52AA36-C8B7-4C5C-956D-F882AF5E148AQ37728510-5B16BF0F-FA10-45F4-BDA1-193C795D178CQ38131264-708253AF-A5BB-41E4-8078-E93DD44FCBF5Q38361935-83B29727-1961-48D7-AC06-C8D21FF01912Q42658274-41BF3831-087A-4600-BA6E-1E8310693BD8Q57816122-C16CBF9D-3471-4AE1-A8BF-CC815EBB06CC
P2860
Current understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trials.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Current understanding of metho ...... ntifolates in clinical trials.
@ast
Current understanding of metho ...... ntifolates in clinical trials.
@en
type
label
Current understanding of metho ...... ntifolates in clinical trials.
@ast
Current understanding of metho ...... ntifolates in clinical trials.
@en
prefLabel
Current understanding of metho ...... ntifolates in clinical trials.
@ast
Current understanding of metho ...... ntifolates in clinical trials.
@en
P1433
P1476
Current understanding of metho ...... ntifolates in clinical trials.
@en
P2093
Bertino JR
Longo-Sorbello GS
P304
P577
2001-02-01T00:00:00Z